Science 37 Holdings, Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Jun-30-21	Dec-31-20	Dec-31-19
	10-K	10-K	10-K/A	10-K	S-1/A
Revenues	70.1	59.6	0.0	23.7	14.1
Revenue growth	17.7%	151.4%		68.3%
Cost of goods sold	54.3	42.4	0.6	22.6	33.2
Gross profit	15.9	17.2	-0.6	1.1	-19.1
Gross margin	22.6%	28.9%		4.7%	-135.8%
Selling, general and administrative	103.3	73.1		28.4
EBITDA [+]	-87.4	-55.9		-27.2	-15.8
EBITDA growth	56.3%	105.3%		72.6%
EBITDA margin	-124.6%	-93.8%		-114.9%	-112.1%
Depreciation and amortization	17.9	7.8		4.4	3.3
EBIT [+]	-105.3	-63.7	-0.6	-31.7	-19.1
EBIT growth	65.3%	101.1%		65.7%
EBIT margin	-150.2%	-106.9%		-133.7%	-135.8%
Non-recurring items [+]	46.7			0.8
Asset impairment	44.1
Interest income	1.7	0.0	0.0	0.1	0.6
Interest income	1.7	0.0	0.0	0.1	0.6
Other income (expense), net [+]	99.2	-30.6		0.7	0.0
Gain (loss) on derivative instruments	98.7	-31.3
Other	-0.3			0.0	0.0
Pre-tax income	-51.2	-94.3	-0.6	-31.7	-18.5
Income taxes	-0.1	0.0	0.0	0.0	0.0
Tax rate	0.2%		0.0%	0.0%	0.0%
Net income	-51.1	-94.3	-0.6	-31.7	-18.5
Net margin	-72.8%	-158.3%		-133.6%	-131.2%

Basic EPS [+]	($0.44)	($2.89)	($0.08)	($2.13)	($2.22)
Growth	-84.7%	35.5%		-4.1%
Diluted EPS [+]	($0.44)	($2.89)	($0.08)	($2.13)	($2.22)
Growth	-84.7%	35.5%		-4.1%

Shares outstanding (basic) [+]	115.9	32.7	6.7	14.9	8.3
Growth	254.6%	119.8%		78.9%
Shares outstanding (diluted) [+]	115.9	32.7	6.7	14.9	8.3
Growth	254.6%	119.8%		78.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.